Muscle

  • XW020 - Open
    • XW020D
      • XW020D8 - Introduction Muscle to New Technology Group 8 with Engineered Allogeneic Thymus Tissue, Open Approach
  • XW023 - Percutaneous
    • XW023S
      • XW023S6 - Introduction Muscle to New Technology Group 6 with COVID-19 Vaccine Dose 1, Percutaneous Approach
    • XW023T
      • XW023T6 - Introduction Muscle to New Technology Group 6 with COVID-19 Vaccine Dose 2, Percutaneous Approach
    • XW023U
      • XW023U6 - Introduction Muscle to New Technology Group 6 with COVID-19 Vaccine, Percutaneous Approach
    • XW023V
      • XW023V7 - Introduction Muscle to New Technology Group 7 with COVID-19 Vaccine Dose 3, Percutaneous Approach
    • XW023W
      • XW023W7 - Introduction Muscle to New Technology Group 7 with COVID-19 Vaccine Booster, Percutaneous Approach
    • XW023X
      • XW023X7 - Introduction Muscle to New Technology Group 7 with Tixagevimab and Cilgavimab Monoclonal Antibody, Percutaneous Approach
    • XW023Y
      • XW023Y7 - Introduction Muscle to New Technology Group 7 with Other New Technology Monoclonal Antibody, Percutaneous Approach